How much does Tafasitamab cost?

Tafasitamab (Tafasitamab) can be used in adults with lenalidomide (Revlimid) to treat certain types of non-Hodgkin lymphoma (a type of cancer that starts with white blood cells that usually fight infection) that come back or don't respond to other treatments in people who can't get a stem cell transplant. Tafaracetam is an injection that belongs to a class of drugs called monoclonal antibodies, which work by helping the body slow or stop the growth of cancer cells.

Tafaracetamab is a powder that is mixed with liquid and injected into a vein by a doctor or nurse in a healthcare setting. Tafaracetamumab is typically administered on days 1, 4, 8, 15, and 22 of cycle 1, on days 1, 8, 15, and 22 of cycles 2 and 3, and on days 1 and 15 of cycles 4 to 12, with each treatment cycle being 28 days long, for a maximum of 12 cycles. The length of treatment depends on how the patient's body responds to the medication and any side effects the patient experiences. If a person is receiving the drug that can cause a serious reaction, the doctor may give the person other drugs to treat or help prevent the reaction to tafasitamumab. Tell your doctor right away if you develop any of the following symptoms, such as chills, flushing, headache, or shortness of breath.

Talfaracetam's single-origin generic drug has not yet been launched in the country, so it is not included in medical insurance. There are European and American versions of Tafaracetam's single-antigen drugs marketed overseas. The American version's specificationsThe price per box of 200 mg may be around 20,000 yuan, and the price of the European version's 200 mg box may be around 10,000 yuan (the price may fluctuate due to exchange rates). The ingredients of the two drugs are basically the same, but the price is more expensive. Currently, there is no generic version of Tafaracetam on the market. For more drug information and specific prices, please consult a medical consultant.